Amiloxate

Amiloxate

SCHEMBL128152

CCCCCC(CC)OC(=O)C(=Cc1ccccc1)OC.COc1ccc(C=CC(=O)OCCC(C)C)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
TDP1 Q9NUW8 2/20 0.57
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
TAS1R3 Q7RTX0 4/20 0.42
TAS1R1 Q7RTX1 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 1/20 0.41
RECQL P46063 1/20 0.41
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
AKR1B10 O60218 1/20 0.38
AKR1B1 P15121 1/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amiloxate SCHEMBL128151 0.86 TDP1 (0.71) LMNATDP1TAS1R3TAS1R1SMN1; SMN2
Cinnamic Acid SCHEMBL14166230 0.83 EGFR (0.44) LMNASMN1; SMN2ALDH1A1CASP3SENP7
Amiloxate SCHEMBL128150 0.82 TDP1 (0.59) LMNATDP1KMT2AMEN1TAS1R3
SCHEMBL25221842 0.81 LMNA (0.56) LMNATDP1KMT2AMEN1ALDH1A1
SCHEMBL14698302 0.81 CTSK (0.44) LMNATDP1KMT2AMEN1ALDH1A1
SCHEMBL62157 0.81 CTSK (0.44) LMNATDP1KMT2AMEN1ALDH1A1
4-Methoxycinnamic Acid SCHEMBL21195188 0.79 TDP1 (0.55) LMNATDP1KMT2AMEN1TAS1R3
SCHEMBL7606022 0.78 TDP1 (0.60) LMNATDP1TAS1R3TAS1R1SMN1; SMN2
SCHEMBL19717782 0.78 CTSK (0.42) LMNATDP1KMT2AMEN1ALDH1A1
SCHEMBL30954277 0.77 TDP1 (0.41) LMNATDP1TAS1R3TAS1R1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1965758-B1 COMPOSITIONS CONTAINING PROTEINS FOR THE TRANSFER/RECYCLING OF STRUCTURALLY MODIFIED LIPIDS, AND THE APPLICATIONS THEREOF MERZ PHARMA GMBH & CO KGAA (DE) 2012-03-07 EP disclosed